New Zealand Professional Investment Services Firm, Forsyth Barr

Forsyth Barr

New Zealand Professional Investment Services Firm

We are proud to be a New Zealand owned firm, with 21 offices throughout the country and over 300 employees. We assist personal, institutional and corporate clients providing a full range of investment services.

Forsyth Barr is a foundation New Zealand Exchange firm (NZX) and accredited market participant. We have been confirmed by the Financial Markets Authority as a Qualifying Financial Entity (QFE).

Research is the cornerstone of our advice. We have one of New Zealand's leading teams of analysts. Our global affiliations ensure comprehensive research coverage of all major investment markets.

Equity Bottom-Up

Vital Healthcare Property Trust / Equity Bottom-Up

<ul><li>VHP reported a solid FY23 result underpinned by acquisitions, development completions and CPI linked rent growth.</li><li>Higher than expected tax was the key variation to our forecasts.</li><li>While FY24 DPS guidance was slightly disappointing it is a minimum, and the timing and value of asset sales could provide upside. </li></ul>

VHP reported a solid FY23 result underpinned by acquisitions, development completions and CPI linked rent growth.Higher than expected tax was the key variation to our forecasts.While FY24 DPS guidance was slightly disappointing it is a minimum, and the timing and value of asset sales could provide upside. 

Vital Healthcare - FY23 Result — Busy Developing

<ul><li>VHP has reported FY23 AFFO +8% to NZ$73.3m reflecting higher rental income from acquisitions, developments, and inflation linked rent growth being partially offset by higher interest and tax.</li><li>However, due to an expanded capital base, AFFO per unit was down -6% on the prior period.</li><li>The result was slightly below our expectations largely due to higher tax expense.</li></ul>

VHP has reported FY23 AFFO +8% to NZ$73.3m reflecting higher rental income from acquisitions, developments, and inflation linked rent growth being partially offset by higher interest and tax.However, due to an expanded capital base, AFFO per unit was down -6% on the prior period.The result was slightly below our expectations largely due to higher tax expense.

Vital Healthcare - FY23 Result First Take – FY24 Guidance Slightly Below

<ul><li>Rising cap rates drive revaluations: Draft 2H23 revaluations of VHP's portfolio resulted in a -NZ$160m movement in asset values with +34bps increase in cap rates partly offset by rent growth and FX movements.</li><li>Asset devaluations more than priced in: The listed equity market had already more than priced in this level of cap rate expansion and asset devaluation.</li><li>Higher gearing being offset through asset sales: We estimate VHP's FY23 gearing to be c.38%, which is creeping towards its management's upper limit of 42.5%.</li></ul>

Rising cap rates drive revaluations: Draft 2H23 revaluations of VHP's portfolio resulted in a -NZ$160m movement in asset values with +34bps increase in cap rates partly offset by rent growth and FX movements.Asset devaluations more than priced in: The listed equity market had already more than priced in this level of cap rate expansion and asset devaluation.Higher gearing being offset through asset sales: We estimate VHP's FY23 gearing to be c.38%, which is creeping towards its management's upper limit of 42.5%.

Vital Healthcare: Benign Revaluation Diagnosis

<ul><li>Solid operational result: VHP reported 1H23 adjusted funds from operations (AFFO) of NZ$37.7m which was just below our forecasts due to lower performance fee add back</li><li>Healthy porfolio metrics: VHP's portfolio metrics remain strong with 98.4% occupancy and a WALT of 17.2 years</li><li>Assets sales to fund the development pipeline: Given current market conditions, VHP is focussed on the completion of its NZ$510m (NZ$369m remaining to spend) development pipeline</li></ul>

Solid operational result: VHP reported 1H23 adjusted funds from operations (AFFO) of NZ$37.7m which was just below our forecasts due to lower performance fee add backHealthy porfolio metrics: VHP's portfolio metrics remain strong with 98.4% occupancy and a WALT of 17.2 yearsAssets sales to fund the development pipeline: Given current market conditions, VHP is focussed on the completion of its NZ$510m (NZ$369m remaining to spend) development pipeline

Vital Healthcare: 1H23 — Also in the Waiting Room

<ul><li><p>NZ drives asset devaluation: VHP expects a 1H23 devaluation of -NZ$65m or c.10cps</p></li><li>One development paused, another one started: VHP is pausing its A$99m Tasman medical centre which was a low yield (4.5%) fund-through project</li><li>Asset sales to manage gearing: VHP expects to divest NZ$200m of non core assets.</li></ul>

NZ drives asset devaluation: VHP expects a 1H23 devaluation of -NZ$65m or c.10cpsOne development paused, another one started: VHP is pausing its A$99m Tasman medical centre which was a low yield (4.5%) fund-through projectAsset sales to manage gearing: VHP expects to divest NZ$200m of non core assets.

Vital Healthcare: Improving Its Vital Signs

New Zealand

Vital Healthcare Property Trust is a property trust that invests in and manages healthcare facilities in New Zealand and Australia.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Vital Healthcare Property Trust (VHP NZ)

Vital Healthcare - FY23 Result — Busy Developing

VHP reported a solid FY23 result underpinned by acquisitions, development completions and CPI linked rent growth. Higher than expected tax was the...

Forsyth Barr

Vital Healthcare - FY23 Result First Take – FY24 Guidance Slightly Below

VHP has reported FY23 AFFO +8% to NZ$73.3m reflecting higher rental income from acquisitions, developments, and inflation linked rent growth being...

Forsyth Barr

Vital Healthcare: Benign Revaluation Diagnosis

Vital Healthcare's (VHP) 2H23 draft valuations have resulted in a -5% reduction in the value of its property assets with larger value declines in...

Forsyth Barr

Vital Healthcare: 1H23 — Also in the Waiting Room

Vital Healthcare (VHP) delivered a solid 1H23 result but slightly below our expectations: VHP reported 1H23 adjusted funds from operations (AFFO)...

Forsyth Barr

Vital Healthcare: Improving Its Vital Signs

Vital Healthcare (VHP) announced 1) a 1H23 asset devaluation, 2) the pause of one of its low yielding development projects, 3) its first life...

Forsyth Barr

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)